Literature DB >> 10512946

Oral urografin in postoperative small bowel obstruction.

S C Chen1, K J Chang, P H Lee, S M Wang, K M Chen, F Y Lin.   

Abstract

The aim of our study was to determine whether Urografin has the potential to offer surgeons a way of differentiating complete from partial small bowel obstruction and whether partial small bowel obstruction can be treated nonoperatively. Altogether 116 patients who had postoperative small bowel obstructions without any toxic signs underwent Urografin studies. Urografin (40 ml) mixed with 40 ml of distilled water was administrated either orally or via nasogastric tube to each patient. Serial plain abdominal radiographs were taken 2, 4, and 8 hours later. A total of 74 patients (63.8%) whose contrast medium reached the colon within the first 8 hours were considered to have partial obstruction and were successfully treated with intravenous hydration and nasogastric decompression. The remaining 42 patients (36.2%) in whom the contrast medium failed to reach the colon within the first 8 hours were regarded as having complete obstruction, and 34 of those patients (81.0%) underwent surgery; 8 (19.0%) received conservative treatment. Adhesion bands with complete bowel obstruction were observed in all 34 patients (100.0%) during laparotomy. Regardless of the presence of an air-fluid level on a plain abdominal radiograph or abdominal pain, a liquid diet followed by a soft diet could be given to those patients whose Urografin emptied into the colon. All the patients with partial bowel obstruction were treated successfully with nonoperative methods. The presence of Urografin in the colon within 8 hours of ingestion as an indicator for nonoperative treatment had a sensitivity of 90.2%, a specificity of 100%, and an accuracy of 93. 1%. Urografin, a safe and reliable water-soluble contrast medium, can be used to differentiate partial intestinal obstruction from complete intestinal obstruction. Early oral intake was found to be a major advantage of Urografin use in this study, and the potential of Urografin use to shorten the period of conservative treatment for postoperative small bowel obstruction needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512946     DOI: 10.1007/s002689900622

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

1.  Small bowel obstruction-who needs an operation? A multivariate prediction model.

Authors:  Martin D Zielinski; Patrick W Eiken; Michael P Bannon; Stephanie F Heller; Christine M Lohse; Marianne Huebner; Michael G Sarr
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

2.  Nonsurgical management of partial adhesive small-bowel obstruction with oral therapy: a randomized controlled trial.

Authors:  Shyr-Chyr Chen; Zui-Shen Yen; Chien-Chang Lee; Yueh-Ping Liu; Wen-Jone Chen; Hong-Shiee Lai; Fang-Yue Lin; Wei-Jao Chen
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  Value of water-soluble contrast (meglumine amidotrizoate) in the diagnosis and management of small bowel obstruction.

Authors:  Saleh Moh'd Al Al Salamah; Fraz Fahim; Shaukat Mahmood Mirza
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

4.  Therapeutic Role of Water-Soluble Contrast Media in Adhesive Small Bowel Obstruction: a Systematic Review and Meta-Analysis.

Authors:  Amanda Koh; Alfred Adiamah; Abeed Chowdhury; Mohamed Khalid Mohiuddin; Balamurali Bharathan
Journal:  J Gastrointest Surg       Date:  2019-08-13       Impact factor: 3.452

5.  Effect of water-soluble contrast in colorectal surgery: a prospective randomized trial.

Authors:  Jia-Hui Chen; Chung-Bao Hsieh; Pei-Chieh Chao; Hsiao-Dung Liu; Chung-Jueng Chen; Yao-Chi Liu; Jyh-Cherng Yu
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

6.  A protocol for the management of adhesive small bowel obstruction.

Authors:  Tyler Loftus; Frederick Moore; Erin VanZant; Trina Bala; Scott Brakenridge; Chasen Croft; Lawrence Lottenberg; Winston Richards; David Mozingo; Linda Atteberry; Alicia Mohr; Janeen Jordan
Journal:  J Trauma Acute Care Surg       Date:  2015-01       Impact factor: 3.313

7.  Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial.

Authors:  Hok-Kwok Choi; Kin-Wah Chu; Wai-Lun Law
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

8.  Prospective evaluation of oral gastrografin(®) in the management of postoperative adhesive small bowel obstruction.

Authors:  Nasrin Rahmani; Reza Ali Mohammadpour; Peyman Khoshnood; Amirhossein Ahmadi; Sara Assadpour
Journal:  Indian J Surg       Date:  2012-04-13       Impact factor: 0.656

Review 9.  Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial.

Authors:  Salomone Di Saverio; Fausto Catena; Luca Ansaloni; Margherita Gavioli; Massimo Valentino; Antonio Daniele Pinna
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

Review 10.  Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention.

Authors:  Fausto Catena; Salomone Di Saverio; Federico Coccolini; Luca Ansaloni; Belinda De Simone; Massimo Sartelli; Harry Van Goor
Journal:  World J Gastrointest Surg       Date:  2016-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.